Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


JMA Campaigns To Support Public Coverage For Vaccinations

This article was originally published in PharmAsia News

Executive Summary

Japan's most influential physician's lobbying group, Japan Medical Association plans to launch a nationwide campaign to urge earlier public coverage for vaccinations such as haemophilus influenzae type B vaccine

You may also be interested in...

Shionogi Eyes Asia Growth As Ping An Alliance Built Out

The alliance between China’s largest insurance group and Shionogi takes concrete shape as investment plans and new Asia companies move ahead, marking a major technology and geographic pivot for the Japanese pharma firm.

Monoclonal Antibodies For COVID-19: Cocktails Present Efficacy, Manufacturing Tradeoffs

Ability to quickly scale manufacturing is a key criteria for Operation Warp Speed therapeutics, but for monoclonal antibodies the most effective approach may mean fewer doses. FDA’s Janet Woodcock said the government is supporting a range of antibody approaches for COVID-19 so that if virus escape mutants emerge from single antibody treatment there will be other options, while Regeneron argues the cocktail approach is safer, even though it will likely mean fewer doses of drug will be available.

QUOTED. 16 July 2020. Martin Walger.

German sickness insurance funds are under unusual financial pressure as a result of the COVID-19 pandemic. And a recent decision to reduce reimbursement for COVID-19 confirmatory tests by one third has left testing labs and diagnostics makers frustrated. See what Martin Walger, chief executive of the German diagnostic industry association (VDGH) said about it here.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts